MedPath

Synergistic effects of N-acetylcysteine combined with common psychological of patients with cannabis use disorder

Phase 3
Completed
Conditions
Patients with cannabis use disorder.
Cannabis abuse with intoxication
F12.12
Registration Number
IRCT20161026030510N5
Lead Sponsor
Iran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
40
Inclusion Criteria

Having the criteria for cannabis abuse based on DSM-5
Being between the ages of 18 and 30 years

Exclusion Criteria

Having a history of brain damage (epilepsy, convulsions, trauma, etc)
Having other underlying medical diseases such as neurological disorders, etc
History of severe psychiatric comorbidity (including schizophrenia, bipolar disorder, and psychotic disorders)
Concomitant use of psychiatric drugs
Concomitant use of drugs abuse other than smoking

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.